Law/Legal
Here's a look at documents from law firms and legal groups
Featured Stories
Caruso Quoted in The Indiana Lawyer's M&A Monthly on Tariffs
MINNEAPOLIS, Minnesota, April 18 [Category: BizLaw/Legal] -- Taft, a law firm, issued the following news:
* * *
Caruso Quoted in The Indiana Lawyer's M&A Monthly on Tariffs
Taft partner Ralph Caruso was featured in the article "Tariffs create uncertainty for M&A activity," which was published on April 17 in The Indiana Lawyer. In the article, Caruso discussed the effects of current tariff uncertainty on corporate M&A deals. He specifically noted that in his talks with clients, they are continually strategizing the best ways to navigate a business strategy in an uncertain economic environment.
... Show Full Article
MINNEAPOLIS, Minnesota, April 18 [Category: BizLaw/Legal] -- Taft, a law firm, issued the following news:
* * *
Caruso Quoted in The Indiana Lawyer's M&A Monthly on Tariffs
Taft partner Ralph Caruso was featured in the article "Tariffs create uncertainty for M&A activity," which was published on April 17 in The Indiana Lawyer. In the article, Caruso discussed the effects of current tariff uncertainty on corporate M&A deals. He specifically noted that in his talks with clients, they are continually strategizing the best ways to navigate a business strategy in an uncertain economic environment.Additionally, Caruso noted that he is seeing a much more cautious and hesitant approach to current M&A deals.
To read the article, please click here. (subscription required)
Caruso is chair of the firm's national Business practice group and a transactional lawyer who has substantial experience advising private equity sponsors and strategic investors in connection with complex domestic and cross-border merger, acquisition, and divestiture transactions. For more than 25 years, Caruso has represented leading private equity sponsors and well-known domestic and multi-national companies in some of their most sensitive and important transactions. He also regularly represents management teams in connection with change of control transactions and investment banks in connection with their sell-side and buy-side engagements.
***
Original text here: https://www.taftlaw.com/news-events/news/caruso-featured-in-the-indiana-lawyers-ma-monthly/
SEC's Reopening of Civil FCPA Case Could Indicate How It Will Navigate Anti-Corruption Cases
NEW YORK, April 18 [Category: BizLaw/Legal] -- Pillsbury, a law firm, issued the following news release:
* * *
SEC's Reopening of Civil FCPA Case Could Indicate How It Will Navigate Anti-Corruption Cases
The Securities and Exchange Commission has asked to stay a civil FCPA enforcement action against two former Cognizant executives a week after they avoided a criminal trial for an alleged bribery scheme in India.
Pillsbury partner David Oliwenstein, a former SEC enforcement lawyer, said the ultimate resolution could indicate how incoming SEC commissioner Paul Atkins, who received U.S. Senate
... Show Full Article
NEW YORK, April 18 [Category: BizLaw/Legal] -- Pillsbury, a law firm, issued the following news release:
* * *
SEC's Reopening of Civil FCPA Case Could Indicate How It Will Navigate Anti-Corruption Cases
The Securities and Exchange Commission has asked to stay a civil FCPA enforcement action against two former Cognizant executives a week after they avoided a criminal trial for an alleged bribery scheme in India.
Pillsbury partner David Oliwenstein, a former SEC enforcement lawyer, said the ultimate resolution could indicate how incoming SEC commissioner Paul Atkins, who received U.S. Senateconfirmation last week, will navigate FCPA enforcement.
"It could be a really big deal, because to the extent there will be a gap in DOJ prosecutions in the anti-corruption space, a big question is [to] what extent the SEC will act to fill that void," he told Global Investigations Review.
He pointed out that the motion did not say the parties had reached an agreement in principle. The SEC is not bound by the President's FCPA pause, he added, and the civil charges would carry a lower burden of proof at trial than the burden on DOJ in the now-dismissed parallel criminal matter.
But he also noted that interim SEC enforcement director Antonia Apps said at a recent conference that her agency would "follow the lead" of the DOJ. The decision to drop the criminal charges "will at least be an important data point" in the commission's internal deliberations, he said.
"The position that the commission takes or doesn't take...may provide a strong signal as to what the next four years are going to look like," he said.
You may find the full article here (subscription required).
***
Original text here: https://www.pillsburylaw.com/en/news-and-insights/sec-reopening-civil-fcpa-case-navigate-anti-corruption.html
Wiley Files Supreme Court Amicus Brief Regarding Federal Sentencing Guidelines
WASHINGTON, April 18 -- Wiley Rein, a law firm, issued the following news release:
* * *
Wiley Files Supreme Court Amicus Brief Regarding Federal Sentencing Guidelines
Wiley, working with the Supreme Court Program at the University of North Carolina (UNC) School of Law, has filed an amicus brief on behalf of the National Association for Public Defense (NAPD) in the U.S. Supreme Court. The brief, supporting the petition for writ of certiorari in Wiggins v. United States, urges the Court to resolve a circuit split concerning the scope of the term "controlled substance offense" under the U.S. Sentencing
... Show Full Article
WASHINGTON, April 18 -- Wiley Rein, a law firm, issued the following news release:
* * *
Wiley Files Supreme Court Amicus Brief Regarding Federal Sentencing Guidelines
Wiley, working with the Supreme Court Program at the University of North Carolina (UNC) School of Law, has filed an amicus brief on behalf of the National Association for Public Defense (NAPD) in the U.S. Supreme Court. The brief, supporting the petition for writ of certiorari in Wiggins v. United States, urges the Court to resolve a circuit split concerning the scope of the term "controlled substance offense" under the U.S. SentencingGuidelines. NAPD is an association of more than 28,000 professionals who deliver the right to counsel throughout all U.S. states and territories.
The case stems from a 2020 federal court conviction in which the Petitioner received an enhanced sentence under the Sentencing Guidelines based on a prior "controlled substance offense." The issue presented is whether a conviction for violation of a state criminal statute extending to substances that are not "controlled substances" under federal law qualifies as a "controlled substance offense" for purposes of the Sentencing Guidelines. The federal courts of appeals are split on that issue.
The NAPD amicus brief argues that the term "controlled substance offense" should be limited to convictions for violation of statutes that apply only to substances qualifying as controlled substances under federal law. The brief explains that this reading serves the goal of the Sentencing Guidelines by ensuring uniformity in federal sentencing for similarly situated defendants. It further argues that this interpretation is supported by the presumption that the meaning of a federal law is not dependent on state law and by the rule of lenity, which favors defendants in cases of ambiguity. The brief also notes that proposed Sentencing Commission amendments would not resolve the circuit split but instead would entrench the contested language.
Read the full brief, here.
Wiley's pro bono representation of NAPD in the amicus brief was led by Richard A. Simpson, partner in the firm's Issues and Appeals, Litigation, and Insurance practices, and associate Elizabeth Fisher, along with co-counsel Andrew Hessick, Judge John J. Parker, UNC's Distinguished Professor of Law and Associate Dean for Strategy & Planning at UNC School of Law. They were assisted by UNC law students Ashlyn Barnes, Connor Fraley, and Hunter Wright.
* * *
Original text and links presented by source here: https://www.wiley.law/pressrelease-Wiley-Files-Supreme-Court-Amicus-Brief-Regarding-Federal-Sentencing-Guidelines
[Category: BizLaw/Legal]
Ropes & Gray Ranked Among Top 5 Law Firms in The Deal's Q1 2025 Private Equity and M&A Global League Tables
BOSTON, Massachusetts, April 18 [Category: BizLaw/Legal] -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Ranked Among Top 5 Law Firms in The Deal's Q1 2025 Private Equity and M&A Global League Tables
The Deal, a leading news and information platform for dealmakers, has ranked Ropes & Gray among the top 5 law firms in its Q1 2025 Private Equity and M&A league tables. The rankings were based on the volume of transactions each firm was noted for between January 1 and March 31, 2025.
Ropes & Gray's award-winning private equity and M&A practice continues to be recognized
... Show Full Article
BOSTON, Massachusetts, April 18 [Category: BizLaw/Legal] -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Ranked Among Top 5 Law Firms in The Deal's Q1 2025 Private Equity and M&A Global League Tables
The Deal, a leading news and information platform for dealmakers, has ranked Ropes & Gray among the top 5 law firms in its Q1 2025 Private Equity and M&A league tables. The rankings were based on the volume of transactions each firm was noted for between January 1 and March 31, 2025.
Ropes & Gray's award-winning private equity and M&A practice continues to be recognizedas one of the world's leading practices by esteemed publications such as Chambers, Legal 500 and others. Additionally, Law360 recently honored Ropes & Gray as a 2024 Private Equity Practice Group of the Year, marking the firm's ninth win of this prestigious award.
For more details, you can view The Deal 's league tables here.
***
Original text here: https://www.ropesgray.com/en/news-and-events/rankings-and-awards/2025/04/ropes-gray-ranked-among-top-5-law-firms-in-the-deals-q1-2025
Cue Biopharma Announces Approximately $20 Million Public Offering
WASHINGTON, April 18 -- WilmerHale, a law firm, issued the following news:
* * *
Cue Biopharma Announces Approximately $20 Million Public Offering
On April 14, 2025, Cue Biopharma, a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, announced the pricing of an underwritten public offering of shares of its common stock and accompanying common stock warrants and, to certain investors, pre-funded warrants to purchase shares of common stock and
... Show Full Article
WASHINGTON, April 18 -- WilmerHale, a law firm, issued the following news:
* * *
Cue Biopharma Announces Approximately $20 Million Public Offering
On April 14, 2025, Cue Biopharma, a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, announced the pricing of an underwritten public offering of shares of its common stock and accompanying common stock warrants and, to certain investors, pre-funded warrants to purchase shares of common stock andaccompanying common stock warrants.
The aggregate gross proceeds of the offering were approximately $20 million, before deducting underwriting discounts and commissions and other offering expenses.
Cue Biopharma also recently announced a strategic research collaboration and license agreement with Boehringer Ingelheim to develop and commercialize Cue Biopharma's CUE-501 product candidate, a differentiated B cell depletion therapy for autoimmune disease.
The team representing Cue Biopharma for the public offering included Cynthia Mazareas, Caroline Dotolo, Erin Bruynell Gallagher and Joe Odegaard.
* * *
Original text and links presented by source here: https://www.wilmerhale.com/en/insights/news/20250417-cue-biopharma-announces-approximately-20-million-public-offering
[Category: BizLaw/Legal]
Ropes & Gray Named Among Winners in China Business Law Journal's Deals of the Year 2024 Awards
BOSTON, Massachusetts, April 18 [Category: BizLaw/Legal] -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Named Among Winners in China Business Law Journal's Deals of the Year 2024 Awards
Ropes & Gray's work representing Bain Capital in Hengrui's out-licensing of its GLP-1 portfolio to Hercules has been named an Intellectual Property Deal of the Year as part of China Business Law Journal's Deals of the Year 2024 Awards.
This transaction was among the deals selected by China Business Law Journal as standout deals of from the past year based on a variety of criteria,
... Show Full Article
BOSTON, Massachusetts, April 18 [Category: BizLaw/Legal] -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Named Among Winners in China Business Law Journal's Deals of the Year 2024 Awards
Ropes & Gray's work representing Bain Capital in Hengrui's out-licensing of its GLP-1 portfolio to Hercules has been named an Intellectual Property Deal of the Year as part of China Business Law Journal's Deals of the Year 2024 Awards.
This transaction was among the deals selected by China Business Law Journal as standout deals of from the past year based on a variety of criteria,including deal size, industry impact, structural innovation, judicial precedent setting, and social contribution.
***
Original text here: https://www.ropesgray.com/en/news-and-events/rankings-and-awards/2025/04/ropes-gray-named-among-winners-in-china-business-law-journal
